HECW2 knockdown suppresses the development of infantile hemangioma by inhibiting ALKBH5/LDHA axis-mediated glycolysis. [PDF]
Peng K +7 more
europepmc +1 more source
Neurodevelopmental Effects of Propranolol Treatment During Infancy in Infantile Hemangioma Patients. [PDF]
Baykan C +11 more
europepmc +1 more source
A Multimodal Approach to a Complex PHACES Patient With Progressive Infantile Hemangioma: A Case Report and Review of Literature. [PDF]
Hicks ED +6 more
europepmc +1 more source
MiR-27b-3p Reduces the Efficacy of Propranolol in the Treatment of Infantile Hemangioma by Inhibiting the Expression of Apaf-1. [PDF]
Li J +8 more
europepmc +1 more source
Digital Imaging and Artificial Intelligence in Infantile Hemangioma: A Systematic Literature Review. [PDF]
Mohamed N, Rabie T.
europepmc +1 more source
The timing and safety of topical timolol treatment for superficial infantile hemangioma: a retrospective cohort study. [PDF]
Xia M +6 more
europepmc +1 more source
Our Experience in Treating Infantile Hemangioma: Prognostic Factors for Relapse After Propranolol Discontinuation. [PDF]
Zaaroura H +3 more
europepmc +1 more source
Efficiency of Topical Beta-Blockers for Epistaxis Control in Ulcerated Infantile Hemangioma. [PDF]
Lam N, Schrepfer T.
europepmc +1 more source
Efficacy and safety assessment of propranolol tablets vs. oral solution for infantile hemangioma: a retrospective study in China. [PDF]
Chen W +8 more
europepmc +1 more source

